Works matching IS 13406868 AND DT 2022 AND VI 29 AND IP 1

Results: 21

FE65 in breast cancer and its clinicopathological significance.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 144, doi. 10.1007/s12282-021-01291-4

By:

Xu, Junyao;
Iwabuchi, Erina;
Miki, Yasuhiro;
Kanai, Ayako;
Ishida, Takanori;
Sasano, Hironobu

Publication type:

Article

Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 164, doi. 10.1007/s12282-021-01294-1

By:

Kamiya, Saki;
Satake, Hiroko;
Hayashi, Yoko;
Ishigaki, Satoko;
Ito, Rintaro;
Kawamura, Mariko;
Taoka, Toshiaki;
Iwano, Shingo;
Naganawa, Shinji

Publication type:

Article

Perceived physical fatigability improves after an exercise intervention among breast cancer survivors: a randomized clinical trial.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 30, doi. 10.1007/s12282-021-01278-1

By:

Qiao, Yujia;
van Londen, G. J.;
Brufsky, Jill W.;
Poppenberg, Janette T.;
Cohen, Rebecca W.;
Boudreau, Robert M.;
Glynn, Nancy W.

Publication type:

Article

Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 1, doi. 10.1007/s12282-021-01307-z

By:

Yotsumoto, Daisuke;
Sagara, Yasuaki;
Kumamaru, Hiraku;
Niikura, Naoki;
Miyata, Hiroaki;
Kanbayashi, Chizuko;
Tsuda, Hitoshi;
Yamamoto, Yutaka;
Aogi, Kenjiro;
Kubo, Makoto;
Tamura, Kenji;
Hayashi, Naoki;
Miyashita, Minoru;
Kadoya, Takayuki;
Saji, Shigehira;
Toi, Masakazu;
Imoto, Shigeru;
Jinno, Hiromitsu

Publication type:

Article

Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study

Published in:

2022

By:

Koh, Su-Jin;
Ohsumi, Shozo;
Takahashi, Masato;
Fukuma, Eisuke;
Jung, Kyung Hae;
Ishida, Takanori;
Dai, Ming-Shen;
Chang, Chuan-Hsun;
Dalvi, Tapashi;
Walker, Graham;
Bennett, James;
O'Shaughnessy, Joyce;
Balmaña, Judith

Publication type:

Correction Notice

Correction to: Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to "A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan"

Published in:

2022

By:

Ozaki, Akihiko;
Tachibana, Kazunoshin;
Ohtake, Tohru

Publication type:

Correction Notice

Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 19, doi. 10.1007/s12282-021-01298-x

By:

Vegunta, Suneela;
Bhatt, Asha A.;
Choudhery, Sadia A.;
Pruthi, Sandhya;
Kaur, Aparna S.

Publication type:

Article

Systematic review of synchronous contralateral axillary metastases in breast cancer: really M1 disease?

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 9, doi. 10.1007/s12282-021-01293-2

By:

Díaz-Roldán, J.;
Eguía-Larrea, M.;
Rubio-Sánchez, T.;
Muñoz-Bellvís, L.

Publication type:

Article

Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.

Published in:

2022

By:

Taira, Naruto;
Kashiwabara, Kosuke;
Tsurutani, Junji;
Kitada, Masahiro;
Takahashi, Masato;
Kato, Hiroaki;
Kikawa, Yuichiro;
Sakata, Eiko;
Naito, Yoichi;
Hasegawa, Yoshie;
Saito, Tsuyoshi;
Iwasa, Tsutomu;
Takashima, Tsutomu;
Aihara, Tomohiko;
Mukai, Hirofumi;
Hara, Fumikata

Publication type:

Correction Notice

Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 174, doi. 10.1007/s12282-021-01295-0

By:

Takahashi, Masato;
Tokunaga, Eriko;
Mori, Joji;
Tanizawa, Yoshinori;
van der Walt, Jan-Stefan;
Kawaguchi, Tsutomu;
Goetz, Matthew P.;
Toi, Masakazu

Publication type:

Article

Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 156, doi. 10.1007/s12282-021-01292-3

By:

Tokunaga, Eriko;
Masuda, Takanobu;
Ijichi, Hideki;
Tajiri, Wakako;
Koga, Chinami;
Koi, Yumiko;
Nakamura, Yoshiaki;
Ohno, Shinji;
Taguchi, Kenichi;
Okamoto, Masahiro

Publication type:

Article

Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 131, doi. 10.1007/s12282-021-01290-5

By:

Taira, Naruto;
Kashiwabara, Kosuke;
Tsurutani, Junji;
Kitada, Masahiro;
Takahashi, Masato;
Kato, Hiroaki;
Kikawa, Yuichiro;
Sakata, Eiko;
Naito, Yoichi;
Hasegawa, Yoshie;
Saito, Tsuyoshi;
Iwasa, Tsutomu;
Takashima, Tsutomu;
Aihara, Tomohiko;
Mukai, Hirofumi;
Hara, Fumikata

Publication type:

Article

LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 65, doi. 10.1007/s12282-021-01281-6

By:

Huang, Shu-Lin;
Huang, Zhong-Cheng;
Zhang, Chao-Jie;
Xie, Jing;
Lei, Shan-Shan;
Wu, Ya-Qin;
Fan, Pei-Zhi

Publication type:

Article

Breast cancer patient-reported outcome of factors influencing cosmetic satisfaction after breast-conserving therapy.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 114, doi. 10.1007/s12282-021-01287-0

By:

Brands-Appeldoorn, A. T. P. M.;
Maaskant-Braat, A. J. G.;
Janssen, L.;
van Osch, L. A. D. M.;
Tjan-Heijnen, V. C. G.;
Roumen, R. M. H.

Publication type:

Article

Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 77, doi. 10.1007/s12282-021-01282-5

By:

Suzuki, Yuna;
Wenwen, Wu;
Ohta, Tomohiko;
Hayashi, Shin-ichi

Publication type:

Article

Integrated analysis of cell cycle-related genes in HR+/HER2− breast cancer.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 121, doi. 10.1007/s12282-021-01289-y

By:

Lai, Jianguo;
Chen, Bo;
Li, Yingzi;
Lin, Xiaoyi;
Li, Min;
Liu, Jing;
Liao, Ning

Publication type:

Article

Correction to: Molecular targeted drugs resistance impairs double‑strand break repair and sensitizes ER‑positive breast cancer to PARP inhibitors.

Published in:

2022

By:

Suzuki, Yuna;
Wenwen, Wu;
Ohta, Tomohiko;
Hayashi, Shin‑ichi

Publication type:

Correction Notice

Sentinel lymph node mapping in breast cancer patients following neoadjuvant chemotherapy: systematic review and meta-analysis about head to head comparison of cN0 and cN + patients.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 50, doi. 10.1007/s12282-021-01280-7

By:

Zarifmahmoudi, Leili;
Aghaee, Atena;
Treglia, Giorgio;
Sadeghi, Ramin

Publication type:

Article

Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 38, doi. 10.1007/s12282-021-01279-0

By:

Lee, Derrick G.;
Schuetz, Johanna M.;
Lai, Agnes S.;
Burstyn, Igor;
Brooks-Wilson, Angela;
Aronson, Kristan J.;
Spinelli, John J.

Publication type:

Article

High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer.

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 103, doi. 10.1007/s12282-021-01286-1

By:

Zhu, Liang;
Pan, Jia-Ni;
Qian, Ziliang;
Ye, Wei-Wu;
Wang, Xiao-Jia;
Cao, Wen-Ming

Publication type:

Article

Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study

Published in:

Breast Cancer (13406868), 2022, v. 29, n. 1, p. 92, doi. 10.1007/s12282-021-01283-4

By:

Koh, Su-Jin;
Ohsumi, Shozo;
Takahashi, Masato;
Fukuma, Eisuke;
Jung, Kyung Hae;
Ishida, Takanori;
Dai, Ming-Shen;
Chang, Chuan-Hsun;
Dalvi, Tapashi;
Walker, Graham;
Bennett, James;
O'Shaughnessy, Joyce;
Balmaña, Judith

Publication type:

Article